ATE329046T1 - Parvovirus-vektoren und deren verwendung - Google Patents

Parvovirus-vektoren und deren verwendung

Info

Publication number
ATE329046T1
ATE329046T1 AT98119409T AT98119409T ATE329046T1 AT E329046 T1 ATE329046 T1 AT E329046T1 AT 98119409 T AT98119409 T AT 98119409T AT 98119409 T AT98119409 T AT 98119409T AT E329046 T1 ATE329046 T1 AT E329046T1
Authority
AT
Austria
Prior art keywords
parvovirus
vector
dna
parvovirus vectors
excisable
Prior art date
Application number
AT98119409T
Other languages
English (en)
Inventor
Jean Rommelaere
Peter Tatersall
Original Assignee
Deutsches Krebsforsch
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Univ Yale filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE329046T1 publication Critical patent/ATE329046T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14341—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14351—Methods of production or purification of viral material
    • C12N2750/14352—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98119409T 1998-10-14 1998-10-14 Parvovirus-vektoren und deren verwendung ATE329046T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98119409A EP1001031B1 (de) 1998-10-14 1998-10-14 Parvovirus-Vektoren und deren Verwendung

Publications (1)

Publication Number Publication Date
ATE329046T1 true ATE329046T1 (de) 2006-06-15

Family

ID=8232796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98119409T ATE329046T1 (de) 1998-10-14 1998-10-14 Parvovirus-vektoren und deren verwendung

Country Status (6)

Country Link
US (1) US7267825B1 (de)
EP (1) EP1001031B1 (de)
AT (1) ATE329046T1 (de)
AU (1) AU6471899A (de)
DE (1) DE69834813T2 (de)
WO (1) WO2000022151A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2266588A1 (de) 2009-06-04 2010-12-29 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Verfahren zur Krebstherapie basierend auf der gleichzeitigen Verabreichung eines Parvovirus und eines Zytokins
EP2368903B1 (de) * 2010-03-26 2014-03-05 Deutsches Krebsforschungszentrum Von einem Adenovirus abgeleitetes Helfervirus zur Steigerung der rekombinanten Parvovirusproduktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302517A (en) * 1987-06-16 1994-04-12 The Board Of Regents Of The University Of Nebraska Method of controlling the expression of a gene in a cell culture, cell culture vector used in the method and method of making the vector
US5585254A (en) * 1987-08-21 1996-12-17 University Of Colorado Foundation, Inc. Autonomous parvovirus gene delivery vehicles and expression vectors
US5436146A (en) * 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
BE1006437A3 (fr) * 1992-12-10 1994-08-30 Company S A Z Sequence nucleotidique destinee au traitement du cancer et des infections.
US5693531A (en) * 1993-11-24 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Vector systems for the generation of adeno-associated virus particles
US5817911A (en) * 1995-04-07 1998-10-06 Regents Of The University Of California Transgenic mice expressing alveolar MCP-1
US5952221A (en) * 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence
US6221646B1 (en) * 1997-07-31 2001-04-24 Chiron Corporation Materials and methods for simplified AAV production

Also Published As

Publication number Publication date
WO2000022151A1 (en) 2000-04-20
DE69834813T2 (de) 2007-05-24
EP1001031B1 (de) 2006-06-07
US7267825B1 (en) 2007-09-11
DE69834813D1 (de) 2006-07-20
AU6471899A (en) 2000-05-01
EP1001031A1 (de) 2000-05-17

Similar Documents

Publication Publication Date Title
DE69939169D1 (de) Aav5 vektoren und deren verwendung
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
DK1100880T3 (da) Urat oxidase
WO2001070276A3 (en) Aav5 vector for transducing brain cells and lung cells
ATE318900T1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
AR031912A2 (es) Subtilasa modificada, acido nucleico, vector, celula microbiana y metodo para producirla
DE69534855D1 (de) Enzymaktive dna moleküle
ATE374247T1 (de) Thymidinkinase mutanten und fusionproteine mit thymidinkinase und guanylatekinase aktivitäten
EP0804609A4 (de) NEUARTIGE AUF p53 ANSPRECHENDE GENE
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
AU2002218166A1 (en) Collections of repeat proteins comprising repeat modules
MX363225B (es) Agentes de enlace selectivos antagonistas de la proteina de enlace de osteoprotegerina.
ATE211174T1 (de) Thymidin-kinase-mutanten
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
WO1996007739A3 (en) Interleukin-1 type 3 receptors
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
DE69232197D1 (de) Klonierung und Expression von Genen, kodierend für Enzyme aus Pilzen, die Arabinan abbauen
ATE329046T1 (de) Parvovirus-vektoren und deren verwendung
DE50005627D1 (de) Chromatographiematerial und verfahren unter verwendung desselben
DE69733948D1 (de) In vivo herstellung von replicativen molekülen
DE59914061D1 (de) Das gen prv-1 und dessen verwendung
ZA9811211B (en) Isolated nucleic acid molecules which encode TAGE molecules, and useS thereof.
ATE374229T1 (de) Granulatförmige organosilan-präparation, verfahren zu ihrer herstellung und ihrer verwendung
ATE239082T1 (de) Dna, welche für eine chitin-synthase aus arthropoden kodiert

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties